Skip to main content

FDA Approvals

FDA Approvals
Invokana (Canagliflozin): First-in-Class SGLT2 Inhibitor Approved for the Treatment of Type 2 Diabetes
Loretta Fala
Read More
FDA Approvals
Nesina, Kazano, and Oseni: Three Alogliptin-Based Agents Approved for the Treatment of Type 2 Diabetes
Loretta Fala
Read More
FDA Approvals
Tafinlar and Mekinist: Two Oral Targeted Kinase Inhibitors for the Treatment of Patients with Metastatic Melanoma and BRAF Mutations
Lisa A. Raedler, PhD, RPh
Read More
FDA Approvals
Simbrinza (Brinzolamide/Brimonidine Tartrate) Receives FDA Approval for the Treatment of Open-Angle Glaucoma or Ocular Hypertension
Loretta Fala
Read More
FDA Approvals
Ilaris (Canakinumab) Receives a New Indication for the Treatment of Systemic Juvenile Idiopathic Arthritis
Lisa A. Raedler, PhD, RPh
Read More
FDA Approvals
Xofigo (Radium Ra 223 Dichloride): The First Alpha Particle–Emitting Radioactive Agent for the Treatment of Castration-Resistant Prostate Cancer with Symptomatic Bone Metastases
Lisa A. Raedler, PhD, RPh
Read More
FDA Approvals
Kadcyla (Ado-Trastuzumab Emtansine): First Antibody-Drug Conjugate Approved for the Treatment of HER2-Positive Metastatic Breast Cancer
Lisa A. Raedler, PhD, RPh
Read More
FDA Approvals
Promising Oncology Drugs in the Pipeline
Caroline Helwick
Read More
FDA Approvals
GI Drugs in Late Development: DDW 2010
Alice Goodman
Read More
FDA Approvals
The Cardiology Pipeline
Wayne Kuznar
Read More
Page 20 of 21
Results 191 - 200 of 202